Biotherapeutics - Свежие новости | |
HYPE coin price up 200%, Sonnet BioTherapeutics merges into Hyperliquid Strategies
The cryptocurrency space has seen a wave of momentum around Hyperliquid, as its native token HYPE continues to surge in value and institutional attention reaches new heights. In a remarkable move that signals growing faith in digital assets, Nasdaq-listed Sonnet BioTherapeutics has announced a strategic merger and rebrand aimed at establishing one of the largest […] дальше »
2025-7-15 19:20 | |
|
Sonnet ditches biotech dreams to anchor a $583m HYPE token reserve
Sonnet BioTherapeutics is no longer just a cancer drug developer. Its $888 million merger will place it among the largest HYPE holders, blurring the lines between traditional finance and decentralized protocols in a high-stakes treasury experiment. According to a July… дальше »
2025-7-15 17:50 | |
|
|
Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. (KOSDAQ: 288330), to Bring Institutionally-Backed, Bitcoin Treasury Company to the South Korean Public Markets:
PRNewswire, PRNewswire, 20th June 2025, Chainwire The post Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. (KOSDAQ: 288330), to Bring Institutionally-Backed, Bitcoin Treasury Company to the South Korean Public Markets: appeared first on CaptainAltcoin. дальше »
2025-6-20 14:52 | |
|
|